Physician

Robert Gilmore Macgregor, M.D.

According to 2025 Medicare claims, Robert Macgregor, M.D. (NPI: 1922201912) practices neurology in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is SAVANNAH NEUROLOGY SPECIALISTS P C (NPI: 1629203294; TIN: 264598467) and primary practice location at 31406-2778.

Macgregor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 800 traditional Medicare patients, billed 127,335 HCPCS/CPT codes, and received $1,084,617 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,678 prescription claims across 703 beneficiaries totaling $3,070,907 in drug costs, led by Austedo (Deutetrabenazine). 2015 DME data shows 11 claims. Open Payments data shows 278 records totaling $104,851. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $222,387 to $1,084,617. Similarly, Part D prescription costs have moved sharply higher in recent years, from $836,260 to $3,070,907. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,572 to $276.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$571K$1.1M2015 Medicare payment: $222,387 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $237,147 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $254,152 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $509,065 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $617,744 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $837,478 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,087,625 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,141,757 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,111,598 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,084,617 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158649,190$222,387
201685013,325$237,147
201784916,866$254,152
201892020,190$509,065
201991828,565$617,744
202098731,209$837,478
20211,02641,688$1,087,625
202293652,246$1,141,757
202383369,338$1,111,598
2024800127,335$1,084,617

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2015 Drug cost: $836,260 (USD; Tot_Drug_Cst)2016 Drug cost: $1,077,467 (USD; Tot_Drug_Cst)2017 Drug cost: $1,155,359 (USD; Tot_Drug_Cst)2018 Drug cost: $1,349,604 (USD; Tot_Drug_Cst)2019 Drug cost: $1,664,057 (USD; Tot_Drug_Cst)2020 Drug cost: $1,951,290 (USD; Tot_Drug_Cst)2021 Drug cost: $2,750,807 (USD; Tot_Drug_Cst)2022 Drug cost: $3,160,773 (USD; Tot_Drug_Cst)2023 Drug cost: $3,221,598 (USD; Tot_Drug_Cst)2024 Drug cost: $3,070,907 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153322,452$836,260
20163992,926$1,077,467
20173962,853$1,155,359
20184723,065$1,349,604
20195293,479$1,664,057
20205473,777$1,951,290
20217574,781$2,750,807
20228265,243$3,160,773
20237484,993$3,221,598
20247034,678$3,070,907

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$184$3682015 Medicare payment: $368 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$368
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more128128$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more406613$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more233278$53
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month100328$46
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's5671,026$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AustedoDeutetrabenazine471,740$562,230
GammaplexImmun Glob G(Igg)/Gly/Iga 0-5020896$449,637
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5016448$442,052
EpidiolexCannabidiol (Cbd)471,410$299,401
GammakedImmune Globul G/Gly/Iga Avg 4623644$150,680

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.277$5,183ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.1$99,669VERTEX PHARMACEUTICALS INCORPORATED
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Gilmore Macgregor, M.D.?

Tedicare shows public-source Medicare data for Robert Gilmore Macgregor, M.D. (NPI 1922201912), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Gilmore Macgregor, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Gilmore Macgregor, M.D.?

Robert Gilmore Macgregor, M.D. is linked to SAVANNAH NEUROLOGY SPECIALISTS P C (billing NPI 1629203294) in the available physician profile data.

Does Robert Gilmore Macgregor, M.D. have Open Payments data?

Robert Gilmore Macgregor, M.D. has 278 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.